Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 280.09 million compared to CNY 316.74 million a year ago. Net income was CNY 35.63 million compared to CNY 26.96 million a year ago.

Basic earnings per share from continuing operations was CNY 0.11 compared to CNY 0.08 a year ago. Diluted earnings per share from continuing operations was CNY 0.11 compared to CNY 0.08 a year ago.